Clinical Study to Evaluate the Maximum Tolerated Dose of BAY79-4620 Given Every 2 Weeks to Patients With Advanced Solid Tumors
Clinical trial NCT01065623 · TERMINATED
Trial details
- NCT number
- NCT01065623
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2010-08-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.